Dichlororibofuranosylbenzimidazole
"Dichlororibofuranosylbenzimidazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Descriptor ID |
D004004
|
| MeSH Number(s) |
D13.570.800.330
|
| Concept/Terms |
Dichlororibofuranosylbenzimidazole- Dichlororibofuranosylbenzimidazole
- Dichlorobenzimidazole Riboside
- Riboside, Dichlorobenzimidazole
- 5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazol
- 5,6 Dichloro 1 beta D ribofuranosyl 1 H benzimidazol
- DRB
- 5,6-Dichloro-1-beta-ribofuranosylbenzimidazole
- 5,6 Dichloro 1 beta ribofuranosylbenzimidazole
|
Below are MeSH descriptors whose meaning is more general than "Dichlororibofuranosylbenzimidazole".
Below are MeSH descriptors whose meaning is more specific than "Dichlororibofuranosylbenzimidazole".
This graph shows the total number of publications written about "Dichlororibofuranosylbenzimidazole" by people in this website by year, and whether "Dichlororibofuranosylbenzimidazole" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Dichlororibofuranosylbenzimidazole" by people in Profiles.
-
Protein kinase CK2 increases glutamatergic input in the hypothalamus and sympathetic vasomotor tone in hypertension. J Neurosci. 2011 Jun 01; 31(22):8271-9.
-
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. 2001; 2(10):RESEARCH0041.
-
Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines. Clin Cancer Res. 2001 Feb; 7(2):267-76.